AI-driven incubator using a proprietary platform to identify and reposition in-licensed, off-strategy drug assets from pharma and biotech into optimal therapeutic applications and clinical development pathways. Data-driven, capital-efficient development that de-risks assets, advances them to clinically meaningful inflection points, and positions assets for licensing via lean portfolio companies with centralized support.